Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial

医学 危险系数 临床终点 置信区间 外科 随机对照试验 放化疗 癌症 内科学 小心等待 新辅助治疗 放射治疗 乳腺癌 前列腺癌
作者
Klara Nilsson,Fredrik Klevebro,Berit Sunde,Ioannis Rouvelas,Mats Lindblad,Éva Szabó,Ingvar Halldestam,Ulrika Smedh,Bengt Wallner,Jan Johansson,Gjermund Johnsen,Eirik Kjus Aahlin,Hans‐Olaf Johannessen,Gabriella Alexandersson von Döbeln,Geir Olav Hjortland,N. Wang,Ying Shang,David Borg,Alexander Quaas,Isabel Bartella
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:34 (11): 1015-1024 被引量:29
标识
DOI:10.1016/j.annonc.2023.08.010
摘要

The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical practice. Observational studies have suggested better outcomes, especially in terms of histological response, after prolonged delay of up to 3 months after nCRT. The NeoRes II trial is the first randomised trial to compare standard to prolonged TTS after nCRT for oesophageal cancer.Patients with resectable, locally advanced oesophageal cancer were randomly assigned to standard delay of surgery of 4-6 weeks or prolonged delay of 10-12 weeks after nCRT. The primary endpoint was complete histological response of the primary tumour in patients with adenocarcinoma (AC). Secondary endpoints included histological tumour response, resection margins, overall and progression-free survival in all patients and stratified by histologic type.Between February 2015 and March 2019, 249 patients from 10 participating centres in Sweden, Norway and Germany were randomised: 125 to standard and 124 to prolonged TTS. There was no significant difference in complete histological response between AC patients allocated to standard (21%) compared to prolonged (26%) TTS (P = 0.429). Tumour regression, resection margins and number of resected lymph nodes, total and metastatic, did not differ between the allocated interventions. The first quartile overall survival in patients allocated to standard TTS was 26.5 months compared to 14.2 months after prolonged TTS (P = 0.003) and the overall risk of death during follow-up was 35% higher after prolonged delay (hazard ratio 1.35, 95% confidence interval 0.94-1.95, P = 0.107).Prolonged TTS did not improve histological complete response or other pathological endpoints, while there was a strong trend towards worse survival, suggesting caution in routinely delaying surgery for >6 weeks after nCRT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
中中中完成签到,获得积分10
刚刚
虚心的爆米花完成签到,获得积分10
刚刚
1秒前
2秒前
SYLH应助科研通管家采纳,获得10
3秒前
我是老大应助科研通管家采纳,获得10
3秒前
领导范儿应助科研通管家采纳,获得10
3秒前
Orange应助科研通管家采纳,获得10
3秒前
乐乐应助科研通管家采纳,获得10
3秒前
今后应助科研通管家采纳,获得10
3秒前
思源应助科研通管家采纳,获得10
3秒前
3秒前
bkagyin应助科研通管家采纳,获得10
3秒前
3秒前
4秒前
5秒前
5秒前
www发布了新的文献求助10
7秒前
长青发布了新的文献求助10
9秒前
jerryang发布了新的文献求助10
10秒前
Chroninus发布了新的文献求助10
11秒前
希望天下0贩的0应助MS903采纳,获得10
12秒前
14秒前
小二郎应助log采纳,获得10
19秒前
20秒前
jerryang完成签到,获得积分20
21秒前
彩色耳机完成签到,获得积分10
21秒前
22秒前
汉堡包应助Twelve采纳,获得10
23秒前
Aoka发布了新的文献求助10
23秒前
偷喝八喜发布了新的文献求助30
24秒前
CipherSage应助lalahulala采纳,获得10
25秒前
王学成完成签到,获得积分10
27秒前
28秒前
28秒前
28秒前
Watsun发布了新的文献求助30
28秒前
shinysparrow应助hyd1640采纳,获得200
29秒前
fly发布了新的文献求助10
29秒前
何以故人初完成签到,获得积分10
32秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3962406
求助须知:如何正确求助?哪些是违规求助? 3508495
关于积分的说明 11141362
捐赠科研通 3241248
什么是DOI,文献DOI怎么找? 1791412
邀请新用户注册赠送积分活动 872861
科研通“疑难数据库(出版商)”最低求助积分说明 803417